The EC Horizon2020 project STriTuVaD aims to demonstrate how advanced computer modelling and simulation can be used to reduce the costs of the clinical trials required to test the efficacy of new therapies for tuberculosis. The consortium published the technical report “A modelling framework to simulate the dynamics of the human immune system”. Please read the for more information STriTuVaD press release 20181214.
